Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

43.1K
Overview
43.1K
Cancer Vaccines01:30

Cancer Vaccines

297
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
297
Immunological Memory01:23

Immunological Memory

473
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
473
Hybridoma Technology01:31

Hybridoma Technology

13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K
Cross-reactivity00:42

Cross-reactivity

30.9K
Overview
30.9K
Development of Immunocompetence01:22

Development of Immunocompetence

271
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influenza Vaccination in Spain: Understanding the Impact of Suboptimal Coverage on Health, Society, and the Economy.

Vaccines·2026
Same author

Measles vaccination status and evidence of immunity among medical students in Catalonia (Spain), 2023-2025: a cross-sectional study.

BMC medical education·2026
Same author

Serological Mumps Evaluation of Medical Students in Catalonia (Spain): Is a Third Dose of Vaccine Needed?

Journal of medical virology·2026
Same author

From methods to policy: a critical appraisal of the 2024 ECDC guidance on enhanced influenza vaccines.

Frontiers in public health·2026
Same author

Comment on Beyond the guidelines: real-world challenges in rabies post-exposure prophylaxis.

Journal of travel medicine·2026
Same author

Documented vaccination as proof of immunity compared to serology in medical students.

Human vaccines & immunotherapeutics·2025
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Related Experiment Video

Updated: May 16, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.1K

What Is Next for COVID-19 Vaccination?

Antoni Trilla1,2,3, Guillem Trilla4,5, Marta Aldea1,2

  • 1Department of Medicine, University of Barcelona Faculty of Medicine and Health Sciences, Barcelona, Barcelona, Spain.

Seminars in Respiratory and Critical Care Medicine
|March 31, 2025
PubMed
Summary
This summary is machine-generated.

New COVID-19 vaccination seasons present challenges in vaccine choice and communication. Improving health information and simplifying recommendations can boost vaccination rates for better protection against evolving SARS-CoV-2 variants.

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.4K

Related Experiment Videos

Last Updated: May 16, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.1K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.4K

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Vaccinology

Background:

  • The SARS-CoV-2 virus continues to evolve, with variants like JN.1, KP.2, and XEC emerging, necessitating updated vaccination strategies.
  • Despite the availability of updated COVID-19 vaccines, booster dose uptake is declining, posing a challenge to maintaining population immunity.

Purpose of the Study:

  • To address the challenges associated with new COVID-19 vaccination seasons, including vaccine selection, identification of high-risk groups, and effective public communication.
  • To explore strategies for improving vaccination coverage and ensuring adequate protection against evolving SARS-CoV-2 variants.

Main Methods:

  • This study is a review and analysis of current COVID-19 vaccination challenges and strategies.
  • It synthesizes information on vaccine effectiveness against dominant SARS-CoV-2 variants and the concept of waning immunity.

Main Results:

  • Updated COVID-19 vaccines are available, targeting predominant SARS-CoV-2 variants.
  • Declining booster dose uptake indicates a need for improved vaccination promotion strategies.
  • Effective communication and simplified recommendations are crucial for increasing vaccination rates.

Conclusions:

  • COVID-19 vaccines remain safe and effective, primarily mitigating disease severity and reducing complications.
  • Enhanced health information, professional training, and simplified recommendations are essential for improving vaccination coverage.
  • Addressing these challenges is vital for public health in the face of persistent and evolving SARS-CoV-2 threats.